Andrew is currently the Market Development Manager with DeNovix Inc. having initially joined the Technical Advisory board in 2012. Prior to DeNovix Inc., Andrew was European Clinical and Translation Medicine Manager with Affymetrix and previously held sales and management roles at Roche Diagnostics in the microarray and next generation sequencing markets. A graduate of the University of Wales, Andrew is a Master of Research in Life Science and is based in the South of England.